Eosinophil: Current Status and Future Perspectives

Dear Colleagues,

This Special Issue "Eosinophil: Current Status and Future Perspectives" presents a comprehensive exploration of the multifaceted role of eosinophils in various physiological and pathological conditions. This Special Issue delves into the dual nature of eosinophils, which can be both beneficial and detrimental in different contexts. It aims to shed light on the nuanced functions of these white blood cells, which have been traditionally associated with allergic reactions and inflammation but are increasingly recognized for their roles in host defense and tissue repair.

This Special Issue invites research articles and reviews that investigate the complex biology of eosinophils, including their activation, migration, and effector functions. It seeks to understand how eosinophils contribute to the resolution of infections, their role in maintaining tissue homeostasis, and their involvement in allergic and inflammatory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and eosinophilic disorders together with cancers.

Furthermore, this Special Issue encourages studies that explore the potential of eosinophils as therapeutic targets, particularly in the context of allergic diseases and cancer, where they have been implicated in both tumor suppression and promotion. It also welcomes research on the development of novel diagnostic tools, predictive biomarkers, and therapeutic strategies to modulate eosinophil activity, with the goal of improving clinical outcomes for patients.

By providing a platform for interdisciplinary research, this Special Issue aims to advance our understanding of eosinophil biology and its implications for human health, fostering new insights into the development of targeted therapies for a range of diseases. Researchers and clinicians are encouraged to contribute their findings to this Special Issue, which promises to be a valuable resource for those interested in immunology, respiratory medicine, and cell biology.

Prof. Dr. Ildiko Horvath
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• eosinophils
• predictive biomarker
• severe asthma
• blood cell count
• anti-eosinophils
• mortality